uniQure NV
QURE·Stocks·Biotechnology·Netherlands·Nasdaq·USD
Price
$19.36
Today
-4.3%
YTD
-18.9%
About
Founded in 1998, uniQure is a gene therapy company that develops treatments for patients with severe genetic diseases. The company has headquarters in Amsterdam and operates within the Netherlands. It is listed on the NASDAQ GS stock market under the ticker QURE.Make the QURE stock an addition to your eToro watchlist for the latest news and information.
Price chart
Closing price history for QURE (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-5.45
P/S (TTM)67.07
P/B (TTM)4.60
Market cap$1.36B
Cap tierSmall-cap
Industry avg P/E-5.31
Profitability
Gross margin13.11%
EBIT margin-1026.94%
Net margin-1178.16%
ROE-88.99%
ROA-25.47%
Earnings & Revenue
Revenue (TTM)$20.17M
Revenue growth (1Y)+28.0%
EPS (TTM)-$3.55
Free cash flow$-192.86M
Total debt$564.44M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.39
Employees221
Next earnings2 Mar '27
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.